국내 Human Research Protection Program 도입 과정과 발전 방향에 대한 고찰

The Korea Human Research Protection Program: Present and Future Direction

  • 박신영 (세브란스병원 임상연구관리실 임상연구보호센터) ;
  • 김진석 (세브란스병원 임상연구관리실 임상연구보호센터)
  • 투고 : 2022.08.18
  • 심사 : 2022.09.25
  • 발행 : 2022.09.30

초록

The Human Research Protection Program (HRPP) includes all subject protection activities and entities involved in the process of planning, reviewing, and conducting clinical research and it ultimately aims that research can be conducted ethically and scientifically while protecting the rights and welfare of research subjects. At the beginning of its introduction in Korea, it was settled down by adopting the United States HRPP, especially the form of AAHRPP element and regulations. However, regulations and operating forms of HRPP have been changed according to the Korean domestic research environment. Actually, all the Korean institutions are adopted the Korean HRPP guidelines that have been officially announced by the Ministry of Food and Drug Safety in Korea. Recently, Korean domestic laws such as the "Advanced Regenerative Biology Act" or "In Vitro Diagnostic Medical Device Act" have been dramatically innovated and our research environment becomes to be more complicated. Therefore, the development of a suitable Korean HRPP model considering the Korean research environment is strongly demanded. For the early settle down of the Korean HRPP model, the positive incentive method should be applied, when the HRPP is operated and/ or properly operated. These improvements in the Korean HRPP environment will eventually lead to the appropriate protection of subjects who are participating in human clinical research and the quality improvement of clinical research.

키워드

참고문헌

  1. Emanuel EJ, Anne W, Fleischman A, Bowen A, Getz KA, Grady C, et al. Oversight of human participants research: Identifying problems to evaluate reform proposals. Ann Int Med 2004;141: 282-91. https://doi.org/10.7326/0003-4819-141-4-200408170-00008
  2. Association for the Accreditation of Human Research Protection Programs (AAHRPP) [Internet]. Washington, DC: AAHRPP; [cited 2022 Jun 7]. Available from: http://www.aahrpp.org.
  3. Ministry of Health and Welfare Committee. Parliamentary inspection of the administration in 2013 [Internet]. Sejong (Korea): Ministry of Health and Welfare; 2013 [cited 2022 Jun 7]. Available from: https://www.google.co.kr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiYl7b05JD4AhUWet4KHWQfCN0QFnoECAsQAQ&url=https%3A%2F%2Fmfds.go.kr%2Fbrd%2Fm_24%2Fdown.do%3Fbrd_id%3Dpblc0010%26seq%3D47954%26data_tp%3DA%26file_seq%3D1&usg=AOvVaw1cQEgLT7DmLAdfO4PhyBHb.
  4. Ministry of Food and Drug Safety. Guidance for operating Human Research Protection Program. Cheongju (Korea): Ministry of Food and Drug Safety; 2014.
  5. Ministry of Food and Drug Safety. 2016 Clinical Trial Inspection Plan. Cheongju (Korea): Ministry of Food and Drug Safety; 2016.
  6. Operational guideline of human research protection program [Internet]. Cheongju (Korea): Ministry of Food and Drug Safety; 2017 [cited 2022 Jun 7]. Available from: https://nedrug.mfds.go.kr/bbs/38/65/.
  7. Regulation for education of persons conducting clinical trials, etc. [Internet]. Sejong (Korea): Korean Law Information Center; [cited 2022 Jun 7]. Available from: https://www.law.go.kr/LSW/admRulLsInfoP.do?admRulSeq=2100000101054.
  8. Maeng CH, Kang SJ, Lee SJ, Yim HW, Choe B, Shin IH, et al. Survey of conflict of interest in the clinical research for IRB members and researchers. J KAIRB 2020;2:23-31.
  9. Current status of clinical trial education institution designation [Internet]. Cheongju (Korea): Ministry of Food and Drug Safety; 2017 [cited 2022 Jun 7]. Available from: https://nedrug.mfds.go.kr/pbp/CCBBQ02.
  10. Association for the Accreditation of Human Research Protection Program (AAHRPP). ACCREDITATION: Why Accreditation Matters? Eligibility. Who is Eligible for Accreditation? [Internet]. Washington, DC; AAHRPP; [cited 2022 Jun 7]. Available from: https://www.aahrpp.org/accreditation/why-accreditation-matters/eligibility.
  11. Park S, Cho SJ, Seo KJ, Kim JS. A survey on the current status of Human Research Protection Program settlement and subject protection activities in Korea. J KAIRB 2021;3:28-36.
  12. Protection of human subjects; reports of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research--Office of the Assistant Secretary for Health, HHS. Notice of availability of reports. Fed Regist 1983;48:34408-12.
  13. Resnik DB. Research ethics timeline [Internet]. Rockville (MD): National Institute of Environmental Health Sciences; [cited 2022 Jun 7]. Available from: https://www.niehs.nih.gov/research/resources/bioethics/timeline/.
  14. Luce JM, Cook DJ, Martin TR, Angus DC, Boushey HA, Curtis JR, et al. The ethical conduct of clinical research involving critically ill patients in the United States and Canada: principles and recommendations. Am J Respir Crit Care Med 2004;170:1375-84. https://doi.org/10.1164/rccm.200406-726ST
  15. Association for the Accreditation of Human Research Protection Program (AAHRPP). AAHRPP history and future: yesterday, today, and tomorrow [Internet]. Washington, DC; AAHRPP; 2022 [cited 2022 Jun 7]. Available from: https://www.aahrpp.org/docs/default-source/default-document-library/aahrpp-history-and-future-(final).pdf?sfvrsn=ce037001_4.
  16. Office for Human Research Protections (OHRP). OHRP database for registered IORGs & IRBs, approved FWAs, and documents received in last 60 days [Internet]. Rockville (MD): OHRP; [cited 2022 Apr 20]. Available from: https://ohrp.cit.nih.gov/search/SrchMtch.aspx.
  17. Association for the Accreditation of Human Research Protection Program (AAHRPP). Evaluation instrument for accreditation [Internet]. Washington, DC; AAHRPP; 2022 [cited 2022 Jun 7]. Available from: http://www.aahrpp.org/resources/for-accreditation/instruments/pdfview/evaluation-instrument-for-accreditation.